Publication | Open Access
In vivo anti-tumour activity of FCE 23762, a methoxymorpholinyl derivative of doxorubicin active on doxorubicin-resistant tumour cells
48
Citations
12
References
1992
Year
Tumor BiologyMedicinal ChemistryDrug TargetingDoxorubicin-resistant Tumour CellsVivo Anti-tumour ActivityMedicinePolymer-drug ConjugateFce 23762Tumor TargetingAnti-cancer AgentPharmacologyRadiation OncologyCancer ResearchDrug Discovery
| Year | Citations | |
|---|---|---|
Page 1
Page 1